MNPR is Monopar Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $116.28. Market cap: $789M. Capital Quality Rank: 49/100 — Stagnant mediocrity.
Stock snapshot
| Price | $116.28 |
| Market cap | $789M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 49 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -17.4% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Safe |
About MNPR
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.
Related non-dividend companies
Other non-dividend stocks investors research alongside MNPR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is MNPR's current stock price?
MNPR (Monopar Therapeutics Inc.) is currently trading at $116.28.
Does MNPR pay a dividend?
MNPR (Monopar Therapeutics Inc.) does not currently pay a regular dividend.
What is MNPR's Capital Quality Rank?
MNPR has a Capital Quality Rank of 49/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track MNPR in DiviDrip
Add MNPR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search MNPR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.